Company intelligence / Profile preview

Tatta Bio

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

Tatta Bio has developed a genomic language model trained on diverse microbial genomes to accelerate the interpretation, discovery, and design of biological sequences. The company aims to unlock new biosolutions by leveraging advances in unsupervised learning applied to genomics. No clinical results as it does not develop therapeutics directly.

Therapeutic areas: Other
Modalities: Genomic intelligenceAI-driven discovery
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Tatta Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tatta Bio.

Explore the full profile